Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPCX
SpaceX
SPCX
|
+$2.3B |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$1.81B |
| 3 |
Marvell Technology
MRVL
|
+$1.71B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$1.11B |
| 5 |
Coca-Cola
KO
|
+$1.03B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.79B |
| 2 |
SNDK
Sandisk
SNDK
|
+$887M |
| 3 |
CTRA
Coterra Energy
CTRA
|
+$762M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$651M |
| 5 |
Vertiv
VRT
|
+$587M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.81% |
| 2 | Financials | 12.23% |
| 3 | Industrials | 9.61% |
| 4 | Healthcare | 9.36% |
| 5 | Consumer Discretionary | 9.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3476
Cumberland Pharmaceuticals
CPIX
$102M
| $703K | ﹤0.01% |
108,413
-5,880
| -5% | -$28.2K |
|
3477
Nerdy
NRDY
$79.5M
| $702K | ﹤0.01% |
51,079
-60,377
| -54% | -$789K |
|
|
PDS
3478
Precision Drilling
PDS
$1.16B
| $702K | ﹤0.01% |
9,161
-490
| -5% | -$44.7K |
|
3479
Central Plains Bancshares
CPBI
| $702K | ﹤0.01% |
36,846
+673
| +2% | +$12.1K |
|
|
IPCX
3480
DELISTED
Inflection Point Acquisition Corp III
IPCX
| $702K | ﹤0.01% |
67,978
+2,387
| +4% | +$24.6K |
|
3481
Summit State Bank
SSBI
$85.7M
| $699K | ﹤0.01% |
51,514
-587
| -1% | -$7.98K |
|
3482
Auburn National Bancorp
AUBN
$92.5M
| $696K | ﹤0.01% |
25,733
+504
| +2% | +$12.4K |
|
3483
HF Foods Group
HFFG
$98.4M
| $695K | ﹤0.01% |
492,847
-497,859
| -50% | -$963K |
|
3484
Transact Technologies
TACT
$53.1M
| $695K | ﹤0.01% |
118,916
+4,868
| +4% | +$19.7K |
|
3485
Research Solutions
RSSS
$74.6M
| $685K | ﹤0.01% |
295,106
-40,053
| -12% | -$95K |
|
|
TIGR
3486
UP Fintech Holding
TIGR
$914M
| $682K | ﹤0.01% |
154,992
-1,473
| -0.9% | -$8.58K |
|
3487
Rani Therapeutics
RANI
$99.9M
| $678K | ﹤0.01% |
890,618
-12,680
| -1% | -$11.2K |
|
3488
Broadway Financial
BYFC
$112M
| $677K | ﹤0.01% |
70,024
+1,041
| +2% | +$9.48K |
|
3489
LanzaTech
LNZA
$80.1M
| $673K | ﹤0.01% |
98,612
+53,780
| +120% | +$850K |
|
3490
Alpha Tau Medical
DRTS
$1.39B
| $672K | ﹤0.01% |
53,399
| – | – |
|
3491
SkinHealth Systems
SKIN
$89.1M
| $665K | ﹤0.01% |
960,374
-1,281,222
| -57% | -$980K |
|
3492
Alset
AEI
$54.8M
| $665K | ﹤0.01% |
461,642
-11,553
| -2% | -$18.3K |
|
|
VWAV
3493
VisionWave Holdings
VWAV
$17.5M
| $664K | ﹤0.01% |
154,441
+37,177
| +32% | +$210K |
|
|
DMAA
3494
Drugs Made In America Acquisition Corp
DMAA
$261M
| $663K | ﹤0.01% |
62,273
| – | – |
|
3495
Westwater Resources
WWR
$71.8M
| $663K | ﹤0.01% |
1,312,223
| – | – |
|
3496
Pliant Therapeutics
PLRX
$71.8M
| $660K | ﹤0.01% |
578,577
+161,303
| +39% | +$196K |
|
3497
Edesa Biotech
EDSA
$45.6M
| $658K | ﹤0.01% |
80,879
+3,825
| +5% | +$34.5K |
|
|
PUSA
3498
Aureus Greenway Holdings
PUSA
$99.7M
| $655K | ﹤0.01% |
164,192
+59,580
| +57% | +$250K |
|
3499
LENSAR
LNSR
$105M
| $653K | ﹤0.01% |
114,331
-115,409
| -50% | -$660K |
|
3500
BARK
BARK
$97M
| $648K | ﹤0.01% |
64,917
-62,685
| -49% | -$588K |
|
Similar funds
Geode Capital Management's Q2 2026 Portfolio in Review
As of Q2 2026, Geode Capital Management held 4,628 positions worth $1.88T, up 17% from $1.61T the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Geode Capital Management's Q2 2026 filing shows 115 new, 3,002 increased, 1,183 reduced and 181 closed positions. Its largest new stake was SpaceX: 13,529,026 shares worth $2.31B. The largest sale was Honeywell, an estimated $1.79B.
By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 31% a quarter earlier, followed by Financials and Industrials.
- Geode Capital Management's largest Q2 2026 buy was SpaceX: 13,529,026 shares worth $2.31B.
- Geode Capital Management added most to Marvell Technology in Q2 2026, an estimated $1.71B increase.
- Geode Capital Management's biggest Q2 2026 reduction was Honeywell, cutting an estimated $1.79B.
- Geode Capital Management fully exited Coterra Energy in Q2 2026, selling an estimated $762M.
- Geode Capital Management's ten largest holdings make up 31% of its $1.88T portfolio in Q2 2026.
- Geode Capital Management opened 115 new positions and closed 181 in Q2 2026.
- Geode Capital Management's portfolio value rose 17% quarter-over-quarter to $1.88T.
Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.